Cargando…
Protease inhibitor plasma concentrations associate with COVID-19 infection
Protease inhibitors influence a range of innate immunity and inflammatory pathways. We quantified plasma concentrations of key anti-inflammatory protease inhibitors in chronic haemodialysis patients with coronavirus disease 2019 (COVID-19). The samples were collected early in the disease course to d...
Autores principales: | Medjeral-Thomas, Nicholas R, Troldborg, Anne, Hansen, Annette G, Pihl, Rasmus, Clarke, Candice L, Peters, James E, Thomas, David C, Willicombe, Michelle, Palarasah, Yaseelan, Botto, Marina, Pickering, Matthew C, Thiel, Steffen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371939/ https://www.ncbi.nlm.nih.gov/pubmed/34458849 http://dx.doi.org/10.1093/oxfimm/iqab014 |
Ejemplares similares
-
Plasma Lectin Pathway Complement Proteins in Patients With COVID-19 and Renal Disease
por: Medjeral-Thomas, Nicholas R., et al.
Publicado: (2021) -
Progressive IgA Nephropathy Is Associated With Low Circulating Mannan-Binding Lectin–Associated Serine Protease-3 (MASP-3) and Increased Glomerular Factor H–Related Protein-5 (FHR5) Deposition
por: Medjeral-Thomas, Nicholas R., et al.
Publicado: (2017) -
Temporal changes in complement activation in haemodialysis patients with COVID-19 as a predictor of disease progression
por: Prendecki, Maria, et al.
Publicado: (2020) -
Highly Increased Levels of Inter-α-inhibitor Heavy Chain 4 (ITIH4) in Autoimmune Cholestatic Liver Diseases
por: Laursen, Tea Lund, et al.
Publicado: (2022) -
Multi-omics identify falling LRRC15 as a COVID-19 severity marker and persistent pro-thrombotic signals in convalescence
por: Gisby, Jack S., et al.
Publicado: (2022)